Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Combinations of interventions to achieve a national HIV incidence reduction goal: insights from an agent-based model.

Gopalappa C, Sansom SL, Farnham PG, Chen YH.

AIDS. 2017 Nov 28;31(18):2533-2539. doi: 10.1097/QAD.0000000000001653.

PMID:
29028657
2.

Progression and Transmission of HIV/AIDS (PATH 2.0).

Gopalappa C, Farnham PG, Chen YH, Sansom SL.

Med Decis Making. 2017 Feb;37(2):224-233. doi: 10.1177/0272989X16668509. Epub 2016 Sep 26.

PMID:
27646567
3.

Challenges in Estimating Effectiveness of Condom Distribution Campaigns to Prevent HIV Transmission.

Shrestha RK, Farnham PG, Whitham HK, Sansom SL.

J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):e35-8. doi: 10.1097/QAI.0000000000001124. No abstract available.

PMID:
27400404
4.

Cost Effectiveness of HIV Prevention Interventions in the U.S.

Lin F, Farnham PG, Shrestha RK, Mermin J, Sansom SL.

Am J Prev Med. 2016 Jun;50(6):699-708. doi: 10.1016/j.amepre.2016.01.011. Epub 2016 Mar 2.

PMID:
26947213
5.

Nearly Half Of US Adults Living With HIV Received Federal Disability Benefits In 2009.

Huang YL, Frazier EL, Sansom SL, Farnham PG, Shrestha RK, Hutchinson AB, Fagan JL, Viall AH, Skarbinski J.

Health Aff (Millwood). 2015 Oct;34(10):1657-65. doi: 10.1377/hlthaff.2015.0249.

PMID:
26438741
6.

Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States.

Hutchinson AB, Farnham PG, Sansom SL, Yaylali E, Mermin JH.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):323-30. doi: 10.1097/QAI.0000000000000838.

7.

From Theory to Practice: Implementation of a Resource Allocation Model in Health Departments.

Yaylali E, Farnham PG, Schneider KL, Landers SJ, Kouzouian O, Lasry A, Purcell DW, Green TA, Sansom SL.

J Public Health Manag Pract. 2016 Nov-Dec;22(6):567-75. doi: 10.1097/PHH.0000000000000332.

8.

Estimating the cost to U.S. health departments to conduct HIV surveillance.

Shrestha RK, Sansom SL, Laffoon BT, Farnham PG, Shouse RL, MacMaster K, Hall HI.

Public Health Rep. 2014 Nov-Dec;129(6):496-504.

9.

Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV.

Hutchinson AB, Ethridge SF, Wesolowski LG, Shrestha RK, Pentella M, Bennett B, Farnham PG, Sullivan T, Patel P, Branson BM.

J Clin Virol. 2013 Dec;58 Suppl 1:e2-7. doi: 10.1016/j.jcv.2013.10.005.

PMID:
24342475
10.

Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era.

Farnham PG, Holtgrave DR, Gopalappa C, Hutchinson AB, Sansom SL.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):e15-8. doi: 10.1097/QAI.0b013e3182a5c8d4. No abstract available.

PMID:
24047975
11.

Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care.

Farnham PG, Gopalappa C, Sansom SL, Hutchinson AB, Brooks JT, Weidle PJ, Marconi VC, Rimland D.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):183-9. doi: 10.1097/QAI.0b013e3182973966.

PMID:
23615000
12.

Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons.

Gopalappa C, Farnham PG, Hutchinson AB, Sansom SL.

J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):99-105. doi: 10.1097/QAI.0b013e31825bd862.

PMID:
22580563
13.

Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions.

Shrestha RK, Sansom SL, Farnham PG.

J Public Health Manag Pract. 2012 May-Jun;18(3):259-67. doi: 10.1097/PHH.0b013e31822b2077.

PMID:
22473119
14.

How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings.

Farnham PG, Sansom SL, Hutchinson AB.

Med Decis Making. 2012 May-Jun;32(3):459-69. doi: 10.1177/0272989X11431609. Epub 2012 Jan 12.

PMID:
22247422
15.

Return on public health investment: CDC's Expanded HIV Testing Initiative.

Hutchinson AB, Farnham PG, Duffy N, Wolitski RJ, Sansom SL, Dooley SW, Cleveland JC, Mermin JH.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):281-6. doi: 10.1097/QAI.0b013e31823e5bee.

PMID:
22067662
16.

The cost-effectiveness of pre-exposure prophylaxis in men who have sex with men in the United States: an epidemic model.

Koppenhaver RT, Sorensen SW, Farnham PG, Sansom SL.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e51-2. doi: 10.1097/QAI.0b013e31822b74fe. No abstract available.

PMID:
21921730
17.

Emergency department HIV screening with rapid tests: a cost comparison of alternative models.

Hutchinson AB, Farnham PG, Lyss SB, White DA, Sansom SL, Branson BM.

AIDS Educ Prev. 2011 Jun;23(3 Suppl):58-69. doi: 10.1521/aeap.2011.23.3_supp.58.

PMID:
21689037
18.

Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis.

Prabhu VS, Farnham PG, Hutchinson AB, Soorapanth S, Heffelfinger JD, Golden MR, Brooks JT, Rimland D, Sansom SL.

PLoS One. 2011;6(5):e19936. doi: 10.1371/journal.pone.0019936. Epub 2011 May 20.

19.

Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings.

Hutchinson AB, Patel P, Sansom SL, Farnham PG, Sullivan TJ, Bennett B, Kerndt PR, Bolan RK, Heffelfinger JD, Prabhu VS, Branson BM.

PLoS Med. 2010 Sep 28;7(9):e1000342. doi: 10.1371/journal.pmed.1000342.

20.

Medical costs averted by HIV prevention efforts in the United States, 1991-2006.

Farnham PG, Holtgrave DR, Sansom SL, Hall HI.

J Acquir Immune Defic Syndr. 2010 Aug;54(5):565-7. doi: 10.1097/QAI.0b013e3181e461b2. No abstract available.

PMID:
20647830

Supplemental Content

Loading ...
Support Center